-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Endava, Lowers Price Target to $13

Benzinga·02/13/2026 13:02:31
Listen to the news
Guggenheim analyst Jonathan Lee maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $15 to $13.